Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/470880

Comparative transcriptome and proteome profiling of the chlorophyll metabolism pathway in four cultivars of Magnolia officinalis

Wu, Q.·Wei, D.·Liu, Y.·Ren, C.·Liu, Q.·Chen, C.·Chen, J.·Pei, J.
View original source ↗Export metadata ↓

Abstract

Magnolia officinalis is an important herb in Chinese medicine that has good therapeutic effects on gastrointestinal motility and helps regulate the spleen and stomach. Magnolia officinalis Rehd.et Wils. (abbreviated as CH) Magnolia officinalis Rehd.et Wils. var. biloba DaAoye (abbreviated as DA) Magnolia officinalis Rehd.et Wils. var. biloba XiaoAoye (abbreviated as XA)Magnolia officinalis Rehd.et Wils. var. biloba Liuye (abbreviated as LY) are the four main cultivars in Dujiangyan city, Sichuan province in China, and DA has better medicinal effects and higher levels of green pigment than the other three cultivars. Proteomics research not only provides new insights into protein expression patterns but also enables the identification of many attractive candidates for further research on the effects of pesticides on chlorophyll metabolism in Magnolia officinalis. Transcriptome and proteome analysis of the four main Magnolia officinalis cultivars in Sichuan province in China identified 125,100 unigenes and 6,012 proteins. Proteomic data and parallel reaction monitoring (PRM) revealed that porphobilinogen deaminase, uroporphyrinogen decarboxylase, oxygen-dependent coproporphyrinogen-III oxidase, protoporphyrinogen oxidase 1, magnesium protoporphyrin IX methyltransferase, magnesium-protoporphyrin IX monomethyl ester oxidative cyclase, and protochlorophyllide reductase-like protein, all of which are involved in chlorophyll synthesis, have higher expression levels in DA than in the other three cultivars. This finding is consistent with the observation that DA has the highest concentration of chlorophyll (37.56 mg/g Fw) of the four cultivars. This research is beneficial to the understanding of the differences in the growth of the four cultivars on the molecular level.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wu, Q., Wei, D., Liu, Y., Ren, C., Liu, Q., Chen, C., Chen, J., Pei, J.. 2018-11-14. Comparative transcriptome and proteome profiling of the chlorophyll metabolism pathway in four cultivars of Magnolia officinalis. https://doi.org/10.1101/470880

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A comparative transcriptomic framework across kidney organoid, assembloid, and transplantation models

Human kidney organoids recapitulate key aspects of renal development and have emerged as valuable platforms for disease modeling, nephrotoxicity screening, and therapeutic development. The field now includes a wide range of emerging protocols with distinct cellular compositions and maturation states, which complicates systematic comparison and model selection. Here, we integrated single-cell and single-nucleus transcriptomes from 11 studies spanning kidney organoid and assembloids, both in vitro and following transplantation, benchmarked against fetal and adult kidney references. Transcriptional maturation toward adult identity is compartment specific and does not correlate with protocol complexity. Assembloid protocols show the most adult-like podocyte and distal nephron signatures, transplantation is associated with enhanced tubular oxidative metabolic features, only protocols incorporating ureteric progenitors reliably generate collecting-duct lineages, and no protocol achieves mature adult proximal tubule identity. Annotating against either fetal or adult kidney reference alone leads to misassignment, because early fetal nephron epithelium transcriptionally resembles injury-dedifferentiated adult proximal tubule cells. Assembloid and transplantation models share elevated mechanosensing pathway expression independently of vascularization. Together, these findings provide a framework for kidney organoid model selection.

bioinformatics↗
bioRxiv2026

OncoSpot enables benchmarking of cancer spatial transcriptomics methods across tumor evolutionary modes

Spatial transcriptomics (ST) is increasingly used to map clonal architecture within tumors, yet methods for analyzing cancer ST data are difficult to evaluate because real tumors lack ground truth for copy-number alterations (CNAs), subclonal identity, and malignant cell fraction. Existing ST simulators model normal tissue and do not represent tumor evolution, CNA-driven expression, or the spatial organization of malignant subclones. We present OncoSpot, a cancer-aware simulator of Visium-like spot-based ST data. OncoSpot combines a spatial evolutionary scaffold from DEMON, CNAs generated along the resulting clonal phylogeny with CNAsim, cancer-type-specific malignant transcriptional programs, and spatially clustered nonmalignant cell types, and aggregates cells into spots with known malignant fraction, subclone, and copy-number profiles. We demonstrate OncoSpot on high-grade serous ovarian carcinoma, colorectal cancer, and hepatocellular carcinoma, which represent three distinct modes of tumor evolution. Simulated subclones were spatially clustered and showed stronger phylogeny-space concordance than those generated by scCube under matched subclone populations. Benchmarking CopyKAT, CancerFinder, Clonalscope, and RCTD revealed cancer-dependent performance: Clonalscope recovered copy-number signals more accurately in ovarian and colorectal cancer, whereas CopyKAT performed better in hepatocellular carcinoma, reflecting both the assumptions of each method and the copy-number landscapes of the three cancers. OncoSpot's ground truth also exposed a failure mode in Clonalscope's malignant spot identification, in which tumor and normal labels were inverted, and allowed us to trace its cause. These method-dependent behaviors would be difficult to detect in real data. OncoSpot provides a framework for benchmarking CNA inference, subclone detection, malignant spot identification, and normal spot deconvolution, and its modular design and guidelines allow extension to additional cancer types. OncoSpot is freely available at https://github.com/compbio-mallory/OncoSpot.

bioinformatics↗
bioRxiv2026

PartiDesign: A structure-sequence co-design paradigm for practical all-to-all biomolecules design

Engineering interactions among biomolecules offers a route to creating new biological functions. Although unified models have advanced biomolecular structure prediction and design, efficient and controllable generation across molecular modalities remains challenging. A key challenge is to couple three-dimensional structure generation with sequence or chemical-identity design across chemically diverse systems. Here, we introduce PartiDesign, a unified structure-sequence co-design model that extends the partially latent framework of La-Proteina to proteins, nucleic acids and small molecules. PartiDesign jointly generates molecular structures and their corresponding sequences or chemical identities, while providing fine-grained control over secondary structure, chemical bonding and amino acid preferences. Across diverse benchmarks for the de novo design of proteins, nucleic acids and small molecules against specified targets, PartiDesign achieved the highest estimated successful-design throughput among the evaluated methods on most benchmarks under the adopted compute-budget protocols. Its configurable constraints further support cyclic peptide and antibody design, allowing generation to be tailored to specific structural and chemical requirements. PartiDesign was developed using 128 Huawei Ascend 910B accelerators, each with 64 GB of memory. The source code is available at https://github.com/MegaGatlingPea/PartiDesign-official, and a freely accessible web server at https://cadd.zju.edu.cn/partidesign/ enables users to generate binding partners without programming expertise. Together, these capabilities provide a versatile and accessible framework for all-to-all biomolecular design, with applications in molecular engineering and drug discovery.

bioinformatics↗